Matsui, J.K.; Perlow, H.K.; Raj, R.K.; Nalin, A.P.; Lehrer, E.J.; Kotecha, R.; Trifiletti, D.M.; McClelland, S., III; Kendra, K.; Williams, N.;
et al. Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors. Biomedicines 2022, 10, 2211.
https://doi.org/10.3390/biomedicines10092211
AMA Style
Matsui JK, Perlow HK, Raj RK, Nalin AP, Lehrer EJ, Kotecha R, Trifiletti DM, McClelland S III, Kendra K, Williams N,
et al. Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors. Biomedicines. 2022; 10(9):2211.
https://doi.org/10.3390/biomedicines10092211
Chicago/Turabian Style
Matsui, Jennifer K., Haley K. Perlow, Rohit K. Raj, Ansel P. Nalin, Eric J. Lehrer, Rupesh Kotecha, Daniel M. Trifiletti, Shearwood McClelland, III, Kari Kendra, Nicole Williams,
and et al. 2022. "Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors" Biomedicines 10, no. 9: 2211.
https://doi.org/10.3390/biomedicines10092211
APA Style
Matsui, J. K., Perlow, H. K., Raj, R. K., Nalin, A. P., Lehrer, E. J., Kotecha, R., Trifiletti, D. M., McClelland, S., III, Kendra, K., Williams, N., Owen, D. H., Presley, C. J., Thomas, E. M., Beyer, S. J., Blakaj, D. M., Ahluwalia, M. S., Raval, R. R., & Palmer, J. D.
(2022). Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors. Biomedicines, 10(9), 2211.
https://doi.org/10.3390/biomedicines10092211
